Will anti-tamper devices be allowed on OTCs and other out-of-scope products after February 2019?
The MHRA has confirmed that subject to the outcome of a public consultation anti-tamper devices may continue to be placed on out-of-scope products after 9th February 2019, if the relevant manufacturer considers that it is necessary to do so in the interests of patient safety.
Similarly, anti-tamper devices may be placed on new out-of-scope products introduced to the market after February 2019, based on a similar risk assessment and on a voluntary basis.
All of which are subject to MHRA approval.